Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 3Fallopian Tube Neoplasms 3Ovarian Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Carcinoma, Ovarian Epithelial 2Urinary Bladder Neoplasms 1Thymoma 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1Neoplasms, Unknown Primary 1Neoplasms 1Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Mediastinal Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Liver Diseases 1Leukemia-Lymphoma, Adult T-Cell 1Congenital Abnormalities 1Carcinoma, Hepatocellular 1Burkitt Lymphoma 1Brenner Tumor 1

Interventions

mogamulizumab 3Cyclophosphamide 3Lenalidomide 2Alemtuzumab 2ruxolitinib 1peginterferon alfa-2b 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1denileukin diftitox 1belinostat 1Zidovudine 1Vincristine 1Raltegravir Potassium 1Prednisone 1Oxaliplatin 1Introns 1Interleukin-15 1Gemcitabine 1Etoposide 1Doxorubicin 1Dexamethasone 1Daclizumab 1Cytarabine 1Cisplatin 1Calcium Dobesilate 1Bortezomib 1B3(Fv)-PE38KDEL recombinant immunotoxin 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia-Lymphoma, Adult T-Cell × belinostat × Clear all
NCT02737046 2026-03-10

Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

University of Miami

Phase 2 Completed
15 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡